Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPABLe: Loperamide and Biofeedback for Fecal Incontinence
NCT02008565Phase 3Completed
- Sponsor
- Pelvic Floor Disorders Network
- Start
- Feb 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of loperamide in fecal incontinence (FI), sponsored by Pelvic Floor Disorders Network. Started Feb 2014; status: completed.
02
Drugs
loperamide
03
Conditions
fecal incontinence (FI)
Beyond the preview
Go deeper on NCT02008565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02008565.